News | April 19, 2024
Fresenius Kabi USA flies complaint against NATCO Pharma
Natco Pharma intends to defend the matter accordingly
Natco Pharma intends to defend the matter accordingly
Submission based on results from pivotal phase III trial showing all primary endpoints met
Oscotec has successfully completed phase 2 study in patients with chronic ITP last year
The pilot plant is focused on scaling up beverage production and will support applications
Varenicline is indicated for smoking cessation in adults
The project aims at screening the general health condition of the students enrolled in classes 6th to 12th.
The registered capital of the newly founded company is € 50 million
Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in a 52-week clinical trial
The workshop was conducted as a part of the NITI–State workshop series
Varenicline Tablets (RLD Chantix) had estimated annual sales of US $412 million in the US
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)